Large drugmakers with the highest profit margins
Net income over the last twelve months as a share of revenue. As of .
- Ranked
- 85
- of 411 large drugmakers we cover
- Median
- −5.1%
- Highest
- 97.7%
- AUPH
- Range
- −97.0% to 97.7%
median −5.1%
−96.9%84.2%
Not ranked: 91 with not a meaningful number, 75 with a margin moved by items that are not sales, 62 with a quarter missing, 11 with no margin to measure, 9 with under $50M of revenue. 78 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
Net margin for other groups
Other rankings of large drugmakers
- Large drugmakers with the lowest PE ratio
- Large drugmakers cheapest against their own PE history
- Large drugmakers with the lowest price to sales ratio
- Large drugmakers with the lowest EV/EBIT
- Large drugmakers with the highest free cash flow yield
- Large drugmakers with the fastest revenue growth
- Large drugmakers with the fastest earnings growth